Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Prasinezumab had seen an efficacy signal in an earlier Phase 2 trial entitled its primary endpoint of slowed movement and non-movement symptoms over 52 weeks on Parts I, II and III of the MDS-UPDRS scale.